image description

Tag: Brad Rovin

How Are the New Lupus Nephritis Guidelines Impacting Treatment?

Recognized as National Kidney Month, March is the ideal time to learn more about the 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Recently issued, the guidelines are designed to provide healthcare providers with up-to-date guidance on the care and treatment of adults and children with lupus […] Read More

Join LRA March 11 to Learn What’s New in Lupus Nephritis

What’s New in Lupus Nephritis? A Research & Treatment Update A Learn from Lupus Webcast Lupus nephritis is a common and dangerous complication of lupus marked by inflammation that can lead to damage and possible failure of the kidney. While up to half of people with lupus develop lupus nephritis, a new survey by the Lupus […] Read More

LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis

September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s New England Journal of Medicine, demonstrating that GSK’s drug Benlysta® (belimumab) significantly improved kidney function in adults with lupus nephritis, the most common severe complication of lupus causing inflammation and serious damage to the kidney. The […] Read More

The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals

November 12, 2019 The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation (NKF) on a free course for healthcare professionals about ways to better diagnose, monitor and treat patients with systemic lupus erythematosus (SLE) and lupus nephritis. The online course is critically important because as the community […] Read More